Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


13.02.2017

2 BMJ
2 Clin Infect Dis
7 J Infect Dis
2 J Virol
2 Lancet Infect Dis
1 N Engl J Med
1 Nat Med
1 Pediatr Infect Dis J
1 Pediatrics
3 PLoS One
1 Proc Natl Acad Sci U S A
18 Vaccine
2 Virology
2 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ

  1. DYER C
    Baby in joint care with local authority to be vaccinated despite mother's objections.
    BMJ. 2017;356:j633.
    PubMed     Text format    

  2. WISE J
    Many vaccines have tiny amounts of inorganic matter, investigation finds.
    BMJ. 2017;356:j596.
    PubMed     Text format    


    Clin Infect Dis

  3. SOETERS HM, Whaley M, Alexander-Scott N, Kanadanian KV, et al
    Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a college - Rhode Island, 2015-2016.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    

  4. FERDINANDS JM, Fry AM, Reynolds S, Petrie JG, et al
    Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011-2012 Through 2014-2015.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


    J Infect Dis

  5. LINDESMITH LC, Mallory ML, Jones TA, Richardson C, et al
    Impact of Pre-Exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.
    J Infect Dis. 2017 Feb 1. doi: 10.1093.
    PubMed     Text format    

  6. UPRETY P, Lindsey JC, Levin MJ, Rainwater-Lovett K, et al
    Inflammation and Immune Activation in Antiretroviral-Treated HIV-1-Infected African Infants and Rotavirus Vaccine Responses.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    

  7. PETRIE JG, Monto AS
    Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    

  8. FEDSON DS
    Statins, Influenza Vaccination and Influenza.
    J Infect Dis. 2016 Dec 7. doi: 10.1093.
    PubMed     Text format    

  9. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  10. Flu vaccine - too much of a good thing?
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    

  11. MARTINEZ-BAZ I, Casado I, Navascues A, Diaz-Gonzalez J, et al
    Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    J Virol

  12. GARCIA-ARRIAZA J, Perdiguero B, Heeney JL, Seaman MS, et al
    HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell i
    J Virol. 2017 Feb 8. pii: JVI.02182-16. doi: 10.1128/JVI.02182.
    PubMed     Text format     Abstract available

  13. JIANG W, Wang S, Chen H, Ren H, et al
    A bivalent heterologous DNA-virus-like particles prime-boost vaccine elicits broad protection against both groups 1 and 2 influenza A viruses.
    J Virol. 2017 Feb 8. pii: JVI.02052-16. doi: 10.1128/JVI.02052.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  14. MORO PL, Sukumaran L
    Cholera vaccination: pregnant women excluded no more.
    Lancet Infect Dis. 2017 Feb 1. pii: S1473-3099(17)30055.
    PubMed     Text format    

  15. ALI M, Nelson A, Luquero FJ, Azman AS, et al
    Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study.
    Lancet Infect Dis. 2017 Feb 1. pii: S1473-3099(16)30523.
    PubMed     Text format     Abstract available


    N Engl J Med

  16. REGULES JA, Beigel JH, Paolino KM, Voell J, et al
    A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.
    N Engl J Med. 2017;376:330-341.
    PubMed     Text format     Abstract available


    Nat Med

  17. KHURANA S, Fuentes S, Coyle EM, Ravichandran S, et al
    Corrigendum: Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.
    Nat Med. 2017;23:264.
    PubMed     Text format    


    Pediatr Infect Dis J

  18. LE MARECHAL M, Agrinier N, Fressard L, Verger P, et al
    Low Uptake of Meningococcal C Vaccination in France: A Cross-Sectional Nationwide Survey of General Practitioners' Perceptions, Attitudes and Practices.
    Pediatr Infect Dis J. 2017 Feb 3. doi: 10.1097/INF.0000000000001553.
    PubMed     Text format     Abstract available


    Pediatrics

  19. SU JR, Leroy Z, Lewis PW, Haber P, et al
    Safety of Second-Dose Single-Antigen Varicella Vaccine.
    Pediatrics. 2017 Feb 7. pii: e20162536. doi: 10.1542/peds.2016-2536.
    PubMed     Text format     Abstract available


    PLoS One

  20. MARANA MH, Jorgensen LV, Skov J, Chettri JK, et al
    Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss.
    PLoS One. 2017;12:e0171944.
    PubMed     Text format     Abstract available

  21. QU F, Weschler LB, Sun Y, Sundell J, et al
    High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.
    PLoS One. 2017;12:e0171438.
    PubMed     Text format     Abstract available

  22. OVSYANNIKOVA IG, Schaid DJ, Larrabee BR, Haralambieva IH, et al
    A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses.
    PLoS One. 2017;12:e0171261.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  23. BRUHN CA, Hetterich S, Schuck-Paim C, Kurum E, et al
    Estimating the population-level impact of vaccines using synthetic controls.
    Proc Natl Acad Sci U S A. 2017 Feb 1. pii: 201612833.
    PubMed     Text format     Abstract available


    Vaccine

  24. PERO SC, Sun YJ, Shukla GS, Carman CL, et al
    Vaccine draining lymph nodes are a source of antigen-specific B cells.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30085.
    PubMed     Text format     Abstract available

  25. CAMPOS IB, Herd M, Moffitt KL, Lu YJ, et al
    IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30079.
    PubMed     Text format     Abstract available

  26. LIU Y, Wang J, Liu S, Du J, et al
    Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30083.
    PubMed     Text format     Abstract available

  27. BERENSON AB, Hirth JM, Fuchs EL
    US medical students' willingness to offer the HPV vaccine by vaccination status.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30077.
    PubMed     Text format     Abstract available

  28. XING Y, Schmitt HJ, Arguedas A, Yang J, et al
    Tick-borne encephalitis in China: A review of epidemiology and vaccines.
    Vaccine. 2017 Jan 30. pii: S0264-410X(17)30032.
    PubMed     Text format     Abstract available

  29. CONTRERAS M, de la Fuente J
    Control of infestations by Ixodes ricinus tick larvae in rabbits vaccinated with aquaporin recombinant antigens.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30117.
    PubMed     Text format     Abstract available

  30. HAMBIDGE SJ, Ross C, Shoup JA, Wain K, et al
    Integration of data from a safety net health care system into the Vaccine Safety Datalink.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30076.
    PubMed     Text format     Abstract available

  31. LIU G, Yin J, Barkema HW, Chen L, et al
    Development of a single-dose recombinant CAMP factor entrapping poly(lactide-co-glycolide) microspheres-based vaccine against Streptococcus agalactiae.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30102.
    PubMed     Text format     Abstract available

  32. BERENSON AB, Croisant S
    Early sexual debut warrants HPV vaccination at an earlier age.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30123.
    PubMed     Text format    

  33. WUMKES ML, van der Velden AM, de Bruin E, Meerveld-Eggink A, et al
    Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30088.
    PubMed     Text format     Abstract available

  34. MCCLENATHAN BM, Stewart DA, Spooner CE, Pathmasiri WW, et al
    Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30122.
    PubMed     Text format     Abstract available

  35. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30128.
    PubMed     Text format     Abstract available

  36. SANCHEZ-RAMOS EL, Monarrez-Espino J, Noyola DE
    Impact of vaccination on influenza mortality in children <5years old in Mexico.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30087.
    PubMed     Text format     Abstract available

  37. BAKER JA, Lewis EL, Byland LM, Bonakdar M, et al
    Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30078.
    PubMed     Text format     Abstract available

  38. HEATON A, Krudwig K, Lorenson T, Burgess C, et al
    Doses per vaccine vial container: An understated and underestimated driver of performance that needs more evidence.
    Vaccine. 2017 Feb 2. pii: S0264-410X(16)31137.
    PubMed     Text format     Abstract available

  39. CROCE E, Hatz C, Jonker EF, Visser LG, et al
    Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and cas
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30113.
    PubMed     Text format     Abstract available

  40. BARMAN S, Krylov PS, Turner JC, Franks J, et al
    Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30127.
    PubMed     Text format     Abstract available

  41. YUK SS, Erdene-Ochir TO, Kwon JH, Noh JY, et al
    Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30082.
    PubMed     Text format     Abstract available


    Virology

  42. LEE YH, Jang YH, Seong BL
    Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Virology. 2017;504:73-78.
    PubMed     Text format     Abstract available

  43. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al
    A live-attenuated influenza vaccine for H3N2 canine influenza virus.
    Virology. 2017;504:96-106.
    PubMed     Text format     Abstract available


    Virus Res

  44. STACHYRA A, Pietrzak M, Maciola A, Protasiuk A, et al
    A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1.
    Virus Res. 2017;232:41-47.
    PubMed     Text format     Abstract available

  45. CZARNECKI MW, Traktman P
    The vaccinia virus DNA polymerase and its processivity factor.
    Virus Res. 2017 Feb 1. pii: S0168-1702(16)30833.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: